we are what we exhale every time that we exhale we release chemicals

We are what we exhale

Every time that we exhaleWe release chemicals

Scientists can analyze our breath

They collect all the chemicals

…and tell you how healthy areyour lungs!

Now imagine what we can do…

lung informationpiece of exhaled air

The answer is…

We are a company that develops medical devices to analyze breath and diagnose “tuberculosis” and“aspergillus” at same TIME!

Why tuberculosis and aspergillus?

Chronic pulmonary aspergillosis is often confused with tuberculosis• Over 3 million affected worldwide • How many in the UK AIAH?

• Images should be uniform• Complement the text• Not impact on copy area

Market

Market

Product: Voltron 1.0

• Evaldas summarize here .• IP property, How much we spent?• And first funding was a grant

Product: Voltron 1.0

In 2014 we started to collect literature information about volatile biomarkers.• First prototype of mask• Validation with clinical trials at the National Center of

Aspergillus in Southern Manchester, notified to the MHRA (Medicines and Healthcare products Regulatory Agency), fee £5,040

• Conformity assessment for CE marking carried out by BSI Healthcare, fee £8,000

• Licensing to Omega Diagnostic Ltd (Manufacture)• Licensing to Avenzys Medical (Distributor)

Feasibility & Sustainability

Operations & Human Resources

Financials & Profitability

Financials & Profitability

Roadmap